Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.
about
Can tissue-based immune markers be used for studying the natural history of cancer?Genome-wide association studies identify four ER negative-specific breast cancer risk lociRisk factors and biomarkers of life-threatening cancersObesity and cancer: mechanistic insights from transdisciplinary studiesPostpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshopClinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challengesBreast cancer risk accumulation starts early: prevention must alsoNew exposure biomarkers as tools for breast cancer epidemiology, biomonitoring, and prevention: a systematic approach based on animal evidenceBody mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor statusDeconvoluting the obesity and breast cancer link: secretome, soil and seed interactionsEstrogen Receptor Status and the Future Burden of Invasive and In Situ Breast Cancers in the United States.Potential of breastmilk analysis to inform early events in breast carcinogenesis: rationale and considerationsBody Mass Index with Tumor 18F-FDG Uptake Improves Risk Stratification in Patients with Breast CancerIVF and breast cancer: a systematic review and meta-analysisBreast cancer subtypes and previously established genetic risk factors: a bayesian approachIdentification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesNormal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expressionFamily history of breast and ovarian cancer and triple negative subtype in hispanic/latina women.Accounting for measurement error in biomarker data and misclassification of subtypes in the analysis of tumor dataThe Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: a unique resource for defining the "molecular histology" of the breast.Overexpression of the HER2/neu Gene: A New Therapeutic Possibility for Patients With Advanced Gallbladder Cancer.Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes.Expression of ERβ gene in breast carcinoma and the relevance in neoadjuvant therapy.Breast cancer in Sub-Saharan Africa: opportunities for prevention.Reproductive risk factors and breast cancer subtypes: a review of the literature.Association between oestrogens receptor expressions in breast cancer and comorbidities: a cross-sectional, population-based study.Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic reviewPassive smoking exposure from partners as a risk factor for ER+/PR+ double positive breast cancer in never-smoking Chinese urban women: a hospital-based matched case control studyAge-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors.Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis.Precision medicine in breast cancer: reality or utopia?A conceptual and methodological framework for investigating etiologic heterogeneityPhytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women.Mimicking pregnancy as a strategy for breast cancer prevention.How many etiological subtypes of breast cancer: two, three, four, or more?Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat padReceptor-defined subtypes of breast cancer in indigenous populations in Africa: a systematic review and meta-analysis.Breast Cancer Risk - Genes, Environment and Clinics.Percent Mammographic Density and Dense Area as Risk Factors for Breast CancerAlcohol and risk of breast cancer in postmenopausal women: an analysis of etiological heterogeneity by multiple tumor characteristics.
P2860
Q24605537-48B7C30F-BCCF-4529-AFE3-85FA7E3449FBQ24622610-DD792570-91D9-4051-9C74-DAF5C7FA3A49Q26774591-0E819FD9-566E-4F68-BCED-7667B983A0F6Q26786829-4A9F22DB-C556-440E-BB8E-B766AA3C8DD6Q26823516-3057E1BD-C586-44B6-A54E-5B1A88AE41D9Q26823978-DBACF373-3C4A-44B9-977E-938BAEA900FBQ26851902-FC41DA1D-064C-4ED7-A461-AE50E5693AC3Q27007828-5065282A-84EF-4CA5-AD9B-86410A7A75A0Q27012792-A42BF6A5-096C-427E-871A-AEF3F6BB4E54Q27012820-1261F84E-E50F-40DF-BD01-E94A485FA435Q27300398-CDE33C3F-0D5F-4C1C-8EE9-7A98DD8E3DA8Q28067818-29B648E5-53B2-4160-A3D6-F0934E1D1137Q28109681-7835F0C6-2DD6-46D2-9FE1-9E267331C4CAQ28295207-9B930ABC-81A6-412B-A7A1-5DA07D73DB8CQ28397311-B22CB28B-932C-4D0D-A681-C00E82F14CF1Q29617680-73FF75EB-75A4-481B-82DF-D12E78985C26Q30539342-BF16D3E4-4E97-4548-BFDB-370F38DE5129Q30620701-EDC4CCB0-F41E-4F14-877C-9A81961C1194Q31123458-EB0BD852-F15A-42CA-AEE9-9609F3D43834Q33454487-570188DE-F1D2-4909-9ADC-DE74774D67ECQ33557258-C5C4A172-2744-4669-91AE-F369D2A19C0AQ33589487-341D68C1-75AE-4BA8-B2F6-25646A6B5896Q33598114-ED1F680D-1585-4ECB-8D62-4ABFCB529E9FQ33622597-D0A5B518-59D9-4C0A-BBEC-C8625A4FA46FQ33632008-6EB66F94-05CF-400B-9A07-083539CBD24FQ33645985-31F6E2E9-BA18-4055-A3DD-65C4CDCD81B9Q33655236-A8E8DF33-51C9-4313-BDA8-AA0C070F0D50Q33670315-CB54144E-1648-4B64-94E7-E992195DE134Q33730347-41AA6961-5256-48A4-8FC5-CB9122A42873Q33751806-1A24D934-F70E-4948-BEAF-BDC08B5605E7Q33809114-1BE3E59F-7300-40AF-9B7B-6062ED65E585Q33923726-26ADBC6F-4569-4D7D-9E8E-B42EB29C1614Q34033220-814BDC90-E56D-4795-A222-94737E6DA2B5Q34040608-3ECD26C4-1377-4518-82C1-1BFBB03705DFQ34106175-4E5E39AA-AFF5-409D-915F-25F6F9C155F6Q34140418-B0D5F4B6-F212-45EC-858C-74EAAF45BF23Q34155727-5C4E533C-68C4-47B4-ABCE-DD20DCBB1D49Q34201805-6AA884E7-B718-4DD7-861E-D5CD57DB6EE5Q34209634-006BC2D9-3B3F-453F-92CC-739CFB384D02Q34230233-8E00700C-D5F8-4F86-B541-4BF86C7BEDFD
P2860
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Associations of breast cancer ...... ssociation Consortium studies.
@ast
Associations of breast cancer ...... ssociation Consortium studies.
@en
type
label
Associations of breast cancer ...... ssociation Consortium studies.
@ast
Associations of breast cancer ...... ssociation Consortium studies.
@en
prefLabel
Associations of breast cancer ...... ssociation Consortium studies.
@ast
Associations of breast cancer ...... ssociation Consortium studies.
@en
P2093
P2860
P50
P356
P1476
Associations of breast cancer ...... ssociation Consortium studies.
@en
P2093
Agnes Jager
Alina Vrieling
Andreas Meyer
Angela Jones
Ann Smeets
Ans M W van den Ouweland
Arndt Hartmann
Beata Peplonska
Beate Pesch
P2860
P304
P356
10.1093/JNCI/DJQ526
P407
P50
P577
2010-12-29T00:00:00Z